[go: up one dir, main page]

MXPA03002323A - Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal. - Google Patents

Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal.

Info

Publication number
MXPA03002323A
MXPA03002323A MXPA03002323A MXPA03002323A MXPA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A
Authority
MX
Mexico
Prior art keywords
methods
colorectal cancer
diagnosis
screening
compositions
Prior art date
Application number
MXPA03002323A
Other languages
English (en)
Inventor
Kurt C Gish
Original Assignee
Eos Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eos Biotechnology Inc filed Critical Eos Biotechnology Inc
Publication of MXPA03002323A publication Critical patent/MXPA03002323A/es

Links

Classifications

    • G01N33/57515
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • G01N33/57535
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MXPA03002323A 2000-09-15 2001-09-14 Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal. MXPA03002323A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66373300A 2000-09-15 2000-09-15
US09/930,020 US20030077568A1 (en) 2000-09-15 2001-08-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
PCT/US2001/028716 WO2002021996A2 (en) 2000-09-15 2001-09-14 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators

Publications (1)

Publication Number Publication Date
MXPA03002323A true MXPA03002323A (es) 2003-08-01

Family

ID=27098811

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002323A MXPA03002323A (es) 2000-09-15 2001-09-14 Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal.

Country Status (7)

Country Link
US (1) US20030077568A1 (es)
EP (1) EP1317669A4 (es)
JP (1) JP2004515225A (es)
AU (1) AU2001290902A1 (es)
CA (1) CA2422278A1 (es)
MX (1) MXPA03002323A (es)
WO (1) WO2002021996A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064946A1 (en) * 2000-08-09 2003-04-03 Mcswiggen James Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1)
US20050233353A1 (en) * 2001-02-27 2005-10-20 Markowitz Sanford D Methods and compositions for categorizing patients
US7118912B2 (en) 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US7081516B2 (en) 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
GB0208089D0 (en) 2002-04-09 2002-05-22 Oxford Glycosciences Uk Ltd Protein
US20040014047A1 (en) * 2002-07-18 2004-01-22 Isis Pharmaceuticals Inc. Antisense modulation of LIM domain kinase 1 expression
EP1546731A2 (en) * 2002-09-30 2005-06-29 Oncotherapy Science, Inc. Method for treating or preventing metastasis of colorectal cancers
US7105657B2 (en) * 2002-11-08 2006-09-12 Board Of Regents Of The University Of Nebraska Compositions and methods for inhibiting pancreatic cancer metastasis
US20060241035A1 (en) 2003-07-11 2006-10-26 Daria Onichtchouk Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
WO2005080597A1 (en) * 2004-02-24 2005-09-01 Oncotherapy Science, Inc. Method for diagnosing colorectal cancers
EP1856286A2 (en) * 2005-02-11 2007-11-21 Wisconsin Alumni Research Foundation Mir-155 assay
JP4759612B2 (ja) * 2005-04-13 2011-08-31 コンセホ スペリオール デ インベスティガシオネス シエンティフィカス 癌治療化合物のin vitroにおける同定方法
EP2166357A1 (en) * 2005-08-18 2010-03-24 Zadec Aps Protein marker for diagnosing colorectal cancer
NZ544432A (en) * 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
NZ593228A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (inhba) for colorectal cancer prognosis
AU2008296927C1 (en) * 2007-09-06 2015-08-13 Case Western Reserve University Methods for diagnosing and treating cancers
RU2565540C2 (ru) * 2007-10-23 2015-10-20 Клиникал Джиномикс Пти. Лтд. Способ диагностики неоплазм-ii
JP2012525159A (ja) * 2009-05-01 2012-10-22 ジェノミック ヘルス, インコーポレイテッド 結腸直腸癌の再発および化学療法に対する応答の可能性における遺伝子発現プロファイルアルゴリズムおよび試験
CN115267189A (zh) * 2022-07-28 2022-11-01 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) Gh作为结直肠癌血清生物标志物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
CA2369319A1 (en) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators

Also Published As

Publication number Publication date
US20030077568A1 (en) 2003-04-24
EP1317669A4 (en) 2005-04-06
CA2422278A1 (en) 2002-03-21
EP1317669A2 (en) 2003-06-11
AU2001290902A1 (en) 2002-03-26
WO2002021996A2 (en) 2002-03-21
WO2002021996A3 (en) 2003-02-06
JP2004515225A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
WO2002068677A8 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
MXPA03002323A (es) Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal.
AU2002245317A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2002347428A1 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AU2002309583A1 (en) Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
AU2001231199A1 (en) Compositions and methods for the early diagnosis of ovarian cancer
AU2002257004A1 (en) Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU3983201A (en) Compositions and methods for the early diagnosis of ovarian cancer
AU3491001A (en) Compositions and methods for the early diagnosis of ovarian cancer
EP1434881A4 (en) METHOD FOR DIAGNOSIS OF CANCER COMPOSITIONS AND METHOD FOR SCREENING ON CANCER MODULATORS
WO2004063355A3 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
AU2002249871A1 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002339865A8 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
MXPA03007827A (es) Metodo y composicion para la coloracion permanente gradual de cabello.
AU3755300A (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
WO2004058153A9 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU3752700A (en) Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
AU4224599A (en) Anti-prostate cancer vaccines, and methods of making, using and evaluating the same
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
AU2002311859A1 (en) Compositions and methods for treating colorectal polyps and cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer